{"title":"Compression equations in pharmaceutical tableting: from classical compaction models to data-driven and mechanistic approaches.","authors":"Tansel Comoglu","doi":"10.1080/10837450.2026.2694094","DOIUrl":null,"url":null,"abstract":"<p><p>Powder compaction remains the key step in pharmaceutical tablet manufacturing, but its multiscale and path-dependent nature makes accurate prediction of tablet properties difficult. Compression equations have long been used to relate applied pressure to densification, porosity, and mechanical strength, providing descriptors for material comparison and formulation design. Classical models such as Heckel, Kawakita-Lüdde, and Cooper-Eaton remain widely used, although they are limited by pressure-range dependence, sensitivity to in-die versus out-of-die measurements, and restricted mechanistic interpretation. Recent developments have expanded compression modeling to include extended in-die formulations incorporating solid compressibility, continuum constitutive laws for finite-element simulations, particle-scale discrete-element approaches, and data-driven process analytical technology (PAT) frameworks. These approaches are critically evaluated alongside classical equations with respect to constitutive validity, calibration transferability, contact-law realism, computational cost, data governance, model drift, and regulatory acceptability. Together, they form a hierarchical modeling framework spanning empirical screening, mechanistic prediction, and real-time process control. This review integrates classical and emerging compaction models and discusses their relevance to critical quality attributes, scale-up, and digital-twin-enabled pharmaceutical manufacturing.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"935-956"},"PeriodicalIF":2.9000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Development and Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10837450.2026.2694094","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Powder compaction remains the key step in pharmaceutical tablet manufacturing, but its multiscale and path-dependent nature makes accurate prediction of tablet properties difficult. Compression equations have long been used to relate applied pressure to densification, porosity, and mechanical strength, providing descriptors for material comparison and formulation design. Classical models such as Heckel, Kawakita-Lüdde, and Cooper-Eaton remain widely used, although they are limited by pressure-range dependence, sensitivity to in-die versus out-of-die measurements, and restricted mechanistic interpretation. Recent developments have expanded compression modeling to include extended in-die formulations incorporating solid compressibility, continuum constitutive laws for finite-element simulations, particle-scale discrete-element approaches, and data-driven process analytical technology (PAT) frameworks. These approaches are critically evaluated alongside classical equations with respect to constitutive validity, calibration transferability, contact-law realism, computational cost, data governance, model drift, and regulatory acceptability. Together, they form a hierarchical modeling framework spanning empirical screening, mechanistic prediction, and real-time process control. This review integrates classical and emerging compaction models and discusses their relevance to critical quality attributes, scale-up, and digital-twin-enabled pharmaceutical manufacturing.
期刊介绍:
Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.
Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:
-Preformulation and pharmaceutical formulation studies
-Pharmaceutical materials selection and characterization
-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation
-QbD in the form a risk assessment and DoE driven approaches
-Design of dosage forms and drug delivery systems
-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies
-Drug delivery systems research and quality improvement
-Pharmaceutical regulatory affairs
This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.